Browsing by Author Llovet i Bayer, Josep Maria
Showing results 35 to 45 of 45
< previous
| Issue Date | Title | Author(s) |
|---|---|---|
| Aug-2020 | Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib in REACH and REACH-2 | Kudo, Masatoshi; Galle, Peter R.; Llovet i Bayer, Josep Maria; Finn, Richard S.; Vogel, Arndt; Motomura, Kenta; Assenat, Eric; Merle, Philippe; Brandi, Giovanni; Daniele, Bruno; Okusaka, Takuji; Tomášek, Jiří; Borg, Christophe; Dadduzio, Vincenzo; Morimoto, Manabu; Pracht, Marc; Jen, Min-Hua; Widau, Ryan C.; Shinozaki, Kenta; Yoshikawa, Reigetsu; Zhu, Andrew X. |
| 1-Jan-2020 | Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trials | Zhu, Andrew X.; Nipp, Ryan D.; Finn, Richard S.; Galle, Peter R.; Llovet i Bayer, Josep Maria; Blanc, Jean Frederic; Okusaka, Takuji; Chau, Ian; Cella, David; Girvan, Alicia; Gable, Jonathon; Bowman, Lee; Wang, Chunxiao; Hsu, Yanzhi; Abada, Paolo; Kudo, Masatoshi |
| 31-Mar-2019 | Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival | Llovet i Bayer, Josep Maria; Montal, Robert; Villanueva, Augusto |
| 20-Mar-2014 | Reply to X. Qi et al ' Brivanib for Hepatocellular Carcinoma Trials: Selection Bias From Barcelona Clinic Liver Cancer Stage?' | Llovet i Bayer, Josep Maria; Johnson, Philip J. |
| 20-Feb-2014 | Search: A phase III, randomized, double-blind, placebo-controlled trial of sorafenib plus erlotinib in patients with advanced hepatocellular carcinoma | Zhu, Andrew X.; Rosmorduc, Olivier; Evans, T.R. Jeffry; Ross, Paul J.; Santoro, Armando; Carrilho, Flair José; Bruix Tudó, Jordi; Qin, Shukui; Thuluvath, Paul J.; Llovet i Bayer, Josep Maria; Leberre, Marie-Aude; Jensen, Markus; Meinhardt, Gerold; Kang, Yoon-Koo |
| 24-Jun-2021 | Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma. | Craig, Amanda J.; Garcia-Lezana, Teresa; Ruiz de Galarreta, Marina; Villacorta-Martin, Carlos; Kozlova, Edgard G; Martins-Filho, Sebastiao N.; von Felden, Johann; Ahsen, Mehmet Eren; Bresnahan, Erin; Hernandez Meza, Gabriela; Labgaa, Ismail; D'Avola, Delia; Schwartz, Myron; Llovet i Bayer, Josep Maria; Sia, Daniela; Thung, Swan N.; Losic, Bojan; Lujambio, Amaia; Villanueva, Augusto |
| 2-Aug-2017 | Translating '–omics' results into precision medicine for hepatocellular carcinoma | Sia, Daniela; Llovet i Bayer, Josep Maria |
| 24-Aug-2017 | Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma | Torrecilla, Sara; Harrington, Andrew N.; Sia, Daniela; Zhang, Zhongyang; Cabellos, Laia; Cornella, Helena; Moeini, Agrin; Campreciós Figueras, Genís; Leow, Wei-Quiang; Fiel, Maria Isabel; Hao, Ke; Bassaganyas, Laia; Mahajan, Milind; Thung, Swan N.; Villanueva, Augusto; Florman, Sander; Schwartz, Myron; Llovet i Bayer, Josep Maria |
| 1-Mar-2017 | Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma | Tovar, Victoria; Cornella, Helena; Moeini, Agrin; Vidal, Samuel; Hoshida, Yujin; Sia, Daniela; Peix, Judit; Cabellos, Laia; Alsinet, Clara; Torrecilla, Sara; Martínez Quetglas, Iris; Lozano Salvatella, Juan José; Desbois-Mouthon, Christele; Sole, Manel; Domingo Domènech, Josep Maria; Villanueva, Augusto; Llovet i Bayer, Josep Maria |
| 1-Apr-2015 | Unique genomic profile of fibrolamellar hepatocellular carcinoma | Cornella, Helena; Alsinet, Clara; Sayols, Sergi; Zhang, Zhongyang; Hao, Ke; Cabellos, Laia; Hoshida, Yujin; Vila Casadesús, Maria; Villanueva, Augusto; Thung, Swan N.; Ward, Stephen C.; Rodríguez-Carunchio, Leonardo; Imbeaud, Sandrine; Lachenmayer, Anja; Quaglia, Alberto; Nagorney David M.; Minguez, Beatriz; Carrilho, Flair José; Robert, Lewis R.; Mazzaferro, Vincenzo; Schwartz, Myron; Esteller, Manel; Heaton, Nigel D.; Zucman-Rossi, Jessica; Llovet i Bayer, Josep Maria |
| 17-Mar-2015 | YAP Inhibition restores Hepatocyte differentiation in advanced HCC, leading to tumor regression | Fitamant, Julien; Kottakis, Filippos; Benhamouche, Samira; Tian, Helen S.; Chuvin, Nicolas; Parachoniak, Christine A.; Nagle, Julia M.; Perera, Rushika M.; Lapouge, Marjorie; Deshpande, Vikram; Zhu, Andrew X.; Lai, Albert; Min, Bosun; Hoshida, Yujin; Avruch, Joseph; Sia, Daniela; Campreciós Figueras, Genís; McClatchey, Andrea I.; Llovet i Bayer, Josep Maria; Morrissey, David; Raj, Lakshmi; Bardeesy, Nabeel |